Adult Smokers

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Feeback groupN/A1 trial
Active Trials
NCT00529256Completed87Est. Apr 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonFeeback group

Clinical Trials (1)

Total enrollment: 87 patients across 1 trials

NCT00529256Johnson & JohnsonFeeback group

Evaluation of Organisational Changes to Promote Smoking Cessation

Start: Dec 2001Est. completion: Apr 200587 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space